PREVAGE Anti-aging Daily Serum protects and corrects the look of skin, helping shield it from environmental assaults and intercepting future aging signs to dramatically improve the look of sun-damaged skin. It's formulated with advanced Idebenone technology, the most powerful antioxidant available today
, which achieved an EPF rating of 95. (
For face products, environmental protection is against oxidative stress due to sun, smoke and pollution, with Idebenone compared to alpha lipoic acid, kinetin, vitamin C, vitamin E and coenzyme Q10.)Advanced Idebenone technology creates a reserve within the skin to release protective and corrective benefits when and where skin needs it most.PREVAGE Anti-aging Daily Serum addresses major skin care concerns with proven results:94% of women saw a dramatic improvement in skin's overall appearance after just 4 weeks.

74% of women saw a reduction in appearance of fine lines and wrinkles after eight weeks.

In addition, PREVAGE Anti-aging Daily Serum achieved the following results in our latest clinical test


:80% improvement in radiance and brightness.70% improvement in skin tone.69% improvement in the look of photo-damaged skin.69% improvement in skin's overall appearance.With continued use, skin's natural look of resilience is fortified, allowing skin to help fight the effects of environmental aggression. For best results, use it morning and night as the first step of your PREVAGE regimen.
When compared to alpha lipoic acid, kinetin, vitamin C, vitamin E and coenzyme Q10. EPF and Environmental Protection Factor are certification marks and trademarks owned by Pharma Cosmetix Research, L.L.C.

For face products, environmental protection is against oxidative stress due to sun, smoke and pollution, with Idebenone compared to alpha lipoic acid, kinetin, vitamin C, vitamin E and coenzyme Q10. EPF and Environmental Protection Factor are certification marks and trademarks owned by Pharma Cosmetix Research, L.L.C.

Consumer test conducted on 102 women age 25-65 over 4 weeks.


12 week clinical test conducted on over 32 women aged 26-64.